Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
ESMO Open
|
April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience
R Moretto, M M Germani, B Borelli, et al.
British Journal of Cancer
|
May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M Di Maio, C Gridelli, C Gallo, et al.
ESMO Open
|
January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial
F Piscaglia, G Masi, E Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study
C Cremolini, F Morano, R Moretto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2018
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016
L Marandino, A La Salvia, C Sonetto, et al.
ESMO Open
|
June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)
A Rossi, A G Leone, M Lambertini, et al.
Current Pharmaceutical Design
|
April 12, 2002
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial
F Perrone, C Gallo, B Daniele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2021
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
E Ghisoni, A Wicky, H Bouchaab, et al.
Journal of Endocrinological Investigation
|
June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, N Marrano, M Montagnani, et al.
ESMO Open
|
June 20, 2025
Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial
R Fazio, G Randon, F Bergamo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
ESMO Open
|
April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience
R Moretto, M M Germani, B Borelli, et al.
British Journal of Cancer
|
May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer
M Di Maio, C Gridelli, C Gallo, et al.
ESMO Open
|
January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial
F Piscaglia, G Masi, E Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study
C Cremolini, F Morano, R Moretto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2018
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016
L Marandino, A La Salvia, C Sonetto, et al.
ESMO Open
|
June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)
A Rossi, A G Leone, M Lambertini, et al.
Current Pharmaceutical Design
|
April 12, 2002
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial
F Perrone, C Gallo, B Daniele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2021
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
E Ghisoni, A Wicky, H Bouchaab, et al.
Journal of Endocrinological Investigation
|
June 27, 2024
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
A Natalicchio, N Marrano, M Montagnani, et al.
ESMO Open
|
June 20, 2025
Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial
R Fazio, G Randon, F Bergamo, et al.
Page
of 9